Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million

Feb 3, 2017

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Feb 2, 2017

Interpace Diagnostics to Present at NobleCon13

Jan 25, 2017

Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock

Jan 20, 2017

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jan 17, 2017

Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock

Jan 3, 2017

Interpace Diagnostics Group Announces 1-for-10 Reverse Split

Dec 28, 2016

Interpace Diagnostics Announces $1.9 Million Registered Direct Offering of Common Stock

Dec 19, 2016

Interpace Diagnostics Announces New Aetna Coverage Policy

Dec 8, 2016

Interpace Diagnostics Reports Third Quarter 2016 Results of Operations

Nov 18, 2016
    • 1...
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin